KNIGHT CAPITOL CONSULTANTS for GENZYME CORPORATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Preserve Access to Affordable Generics Act (S. 369), possible patent related provisions in supplemental appropriations bill (H.R. 4899)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | previously listed |
Health Issues HCR
Implementation of, and possible changes to health care reform legislation and particularly issues of interest to the biotechnology industry, including follow-on biologics, comparative effectiveness, orphan drugs, drugs provided at clinics under 340B of the Public Health Service Act, and import safety (H.R. 3590, the Patient Protection and Affordable Care Act, and H.R. 4872, the Health care and Education Reconciliation Act of 2010, H.R. 4313, Tax Extenders legislation)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Prof Staff, House Appropriations Cmte |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.